Do we need new indicators of dialysis adequacy based on middle-molecule removal?

Nature Clinical Practice Nephrology

Volumn 4, Issue 4, 2008, Pages 174-175

  Vanholder, Raymond ^a,b   Eloot, Sunny ^a   Van Biesen, Wim ^a,b  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; GUANIDINOSUCCINIC ACID; METHYLGUANIDINE; UREMIC TOXIN;

CLINICAL EFFECTIVENESS; DIALYSIS; HEMODIALYSIS; HUMAN; KINETICS; MOLECULAR WEIGHT; OUTCOME ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; SHORT SURVEY; SURVIVAL RATE; UREMIA;

HUMANS; MEMBRANES, ARTIFICIAL; RENAL DIALYSIS; TOXINS, BIOLOGICAL; UREA; UREMIA;

EID: 41349100068     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0750     Document Type: Short Survey

References (13)

1. Lowrie EG et al. (1981) Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 305: 1176-1181
2. Gotch FA and Sargent JA (1985) A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28: 526-534
3. Vanbelleghem H et al. (2007) The Kidney Disease: improving Global Outcomes website: comparison of guidelines as a tool for harmonization. Kidney Int 71: 1054-1061
4. Johnson WJ et al. (1972) Effects of urea loading in patients with far-advanced renal failure. Mayo Clin Proc 47: 21-29
5. Eloot S et al. (2005) Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds. Kidney Int 67: 1566-1575
6. Eloot S et al. (2007) Impact of hemodialysis duration on the removal of uremic retention solutes. Kidney Int [doi:10.1038/sj.ki. 5002750]
7. Eknoyan G et al. (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019
8. Vanholder R et al. (2003) Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63: 1934-1943
9. Vanholder R et al. (2001) Uremic toxicity: present state of the art. Int J Artif Organs 24: 695-725
10. Vanholder R et al.: The middle molecule hypothesis thirty years after: lost and rediscovered in the universe of uremic toxicity? J Nephrol, in press
11. Revillard JP et al. (1982) Beta 2-microglobulin and beta 2-microglobulin-binding proteins in inflammatory diseases. Eur J Rheumatol Inflamm 5: 398-405
12. Cheung AK et al. (2006) Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 17: 546-555
13. Ward RA et al. (2000) A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol 11: 2344-2350